Dr Merlin Goldman

1

Technology Strategy Board
Technologies for Health
Dr Merlin Goldman Lead Technologist Bioscience
and Healthcare
2
Background

• Protein Chemist
• PPL Therapeutics
• Research
• Biochemical Engineer
• Serologicals (now Celliance)
• Manufacturing
• Validation Scientist
• Wyeth Biotech
• Development

3
Key Technology and Application Areas

• Key Technologies
• Advanced Manufacturing
• Advanced Materials
• Bioscience
• Electronics, Photonics Electrical Systems
• Information and Communication Technologies

• Key Applications
• Environmental Sustainability
• Energy Generation Transmission
• Healthcare
• Transport (esp. aerospace automotive)
• Creative Industries
• High Value Services

4
Criteria for Support

• UK capacity to develop and exploit the technology
• Potential for impact and timescale
• The size of the global market opportunity
• A clear role for the Technology Strategy Board

5
Collaborative RD Competition currently running

• Technologies for Health - Phase 2
• Opened 19 December 2007
• Deadline for submission by 22nd February 2008
• Close 27th March 2008

6
21st Healthcare

• Ronnie Barker as a doctor on a computer screen in
  an examination room, speaking to Ronnie Corbett,
  the patient, "Please choose one of the following
  options Do you suffer from any of the following
• A - A bleeding nose,
• B - Getting out of bed in the morning,
• C - Terry Wogan, or
• D - all three Terry Wogan getting up your
  bleeding nose every morning."

7
Council for Science and Technology (CST)

• November 2007, CST recommended 5 technologies
  that could accelerate the real returns for the UK
  within a five-year timeframe are
• Carbon Capture and Storage
• Disaster Mitigation Technologies
• Low Carbon Distribution Networks for Electricity
  Generation
• Medical Devices
• E-Health
• Plastic Electronics

8
NHS Renewal

• January 2008
• Gordon Brown pledged to make the renewal of the
  NHS his "highest priority" as he unveiled a major
  new national health screening programme. Patients
  in England will be offered screening for early
  signs of heart disease, strokes and kidney
  disease.

9
Challenges

• to bring medical diagnosis, care and analytical
  capabilities closer to the patient community
• by applying advanced hardware systems and
  miniaturisation technologies to develop more
  portable and lower-cost equipment

10
Opportunities

• The global market for medical devices is 120
  billions plus a further 23 billions for the
  diagnostics market
• The UK market, at gt 5.4 billion is in the top 5
  markets in Europe
• Healthcare markets are growing at 7-12 per year
• The estimated market by 2015 is 240 billion

11
Technologies for Health Scope

• Applications likely to improve quality of life
  with a well-defined end-use,
• Minimally invasive, implantable wearable
  devices,
• Early rapid detection of disease point-of-care
  analysis diagnosis,
• Point-of-use drug synthesis/delivery drug
  efficacy tests imaging for use with biomarkers
• Animal health

12
Technologies

• Potential technologies
• Photonics lasers, optical fibres, fluorescence,
  spectroscopy, imaging.
• Electronics sensors (esp. bio- or
  chemo-sensitive)
• Microfluidics, microsystems, nanodevices
• Telecommunications data capture and
  transmission.

13
Summary

• Bringing diagnosis and treatment closer to the
  patient
• Use of sophisticated or simple technologies
• Innovation
• Business-led or business minded

14

Dr Merlin Goldman Lead Technologist Bioscience
and Healthcare Technology Strategy Board Block
B, Floor 1 North Star House North Star
Avenue Swindon SN2 1JF   merlin.goldman_at_tsb.gov.uk
Switchboard 01793 442700 Direct 01793
442730 Mobile [phone]